Ciprofibrate

This classification denotes an anti-lipidemic agent with the molecular formula C13H14Cl2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F8252JGO9S, chemically known as 2-(p-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropionic acid but generally known as ciprofibrate, which bears US NIH Compound Identifier 2763. European Medicines Agency schedules Ciprofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07469MIG. The term CIPROFIBRATE is an International Non-Proprietary Name. World Health Organization schedules ciprofibrate in its Anatomical Therapeutic Chemical (ATC) Classification. CIPROFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciprofibrate under HS 29189900 and SITC 51396. As of Q4 2014, CIPROFIBRATE remains the US FDA Preferred Term for this commodity. Ciprofibrate bears US NLM identifiers UMLS ID C0055775 and NCI Concept Code C87471. SMILES: ClC1(Cl)C(C1)c1ccc(OC(C)(C)C(=O)O)cc1.